FDA-Inspected Site

Celgene Corporation

19 FDA inspections are on record for Celgene Corporation in Summit, United States.

483· Form 483 issued

Summit, United States · Last updated July 9, 2026

Overview

  • 19 FDA inspections are on record.
  • 8 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-07-18.

At a glance

Inspections

19

Form 483s

8

EIRs

5

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
14 Jul 2025 – 18 Jul 2025Biologics483On file
2 Dec 2024 – 6 Dec 2024Human Drugs483View 483 →
3 Sep 2024 – 6 Sep 2024Human DrugsClean
29 Jan 2024 – 31 Jan 2024Human DrugsClean
5 Jun 2023 – 16 Jun 2023Biologics483View 483 →
7 Mar 2022 – 14 Mar 2022Human DrugsClean
15 Feb 2021 – 19 Feb 2021Biologics483On file
26 May 2020 – 3 Jun 2020Human DrugsClean
8 Jul 2019 – 26 Jul 2019Human DrugsClean
25 Jun 2018 – 27 Jun 2018Human DrugsClean
13 Mar 2017 – 17 Mar 2017Human DrugsClean
19 Dec 2016 – 25 Jan 2017Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

6 Dec 2024
FDCA 505-1(f)(3)(A)

Failure to comply with REMS Elements to Assure Safe Use (ETASU) A

Cited by Tyanna N Hadley

6 Dec 2024
FDCA 505-1(f)(3)(B)

Failure to comply with REMS Elements to Assure Safe Use (ETASU) B

Cited by Tyanna N Hadley

6 Dec 2024
FDCA 505-1(f)(3)(E)

Failure to comply with REMS Elements to Assure Safe Use (ETASU) E

Cited by Tyanna N Hadley

6 Dec 2024
FDCA 505-1(f)(4)

Failure to comply with REMS Implementation System

Cited by Tyanna N Hadley

16 Jun 2023
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Unnee Ranjan, Helen B Ricalde, Emily A Walters

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 314.80(b)Cited across public-safe Form 483 observations2x
21 CFR 314.80(c)(1)(i)Cited across public-safe Form 483 observations2x
21 CFR 314.80(c)(2)Cited across public-safe Form 483 observations2x
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.137(a)Cited across public-safe Form 483 observations1x
21 CFR 211.165(d)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(5)Cited across public-safe Form 483 observations1x
21 CFR 314.80(c)(1)(ii)Cited across public-safe Form 483 observations1x
FDCA 505-1(f)(3)(A)Cited across public-safe Form 483 observations1x
FDCA 505-1(f)(3)(B)Cited across public-safe Form 483 observations1x
FDCA 505-1(f)(3)(E)Cited across public-safe Form 483 observations1x
FDCA 505-1(f)(4)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Celgene Corporation's 8 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat